ACTIVITIES TO PROMOTE RESEARCH COLLABORATION
Application Receipt Date: March 15, 2010
FY 2010 Guidelines and Information for Applicants
Announcement
The Division of Cancer Biology (DCB) at the National Cancer Institute (NCI) announces for the Federal fiscal year of 2010 the opportunity for current DCB grantees to seek supplemental funding for existing DCB-funded research projects to support and encourage multidisciplinary scientific collaboration among DCB and NCI grantees, as well as with other members of the scientific community. This initiative known as the Division of Cancer Biology Activities to Promote Research Collaborations (DCB-APRC) Program can support novel collaborative activities in cancer biology that bring together new ideas and approaches from disparate scientific disciplines. The proposed DCB-APRC activities must be within the overall scope of the active parent DCB grant.
This is a one-time announcement with a single receipt date of March 15, 2010. Late applications will not be accepted. Requests must be submitted as described in these DCB-APRC Program guidelines. Although the financial plans of the NCI provide support for this program, administrative supplement awards pursuant to this initiative are contingent upon the availability of funds and the receipt of a sufficient number of meritorious requests.
The DCB-APRC Program is anticipated to be highly competitive with limited funding; only a few supplements will be awarded. Before submission, all grantees are strongly encouraged to contact their DCB Program Director to discuss the planned collaboration and application.
This document describes the: (1) purpose; (2) background; (3) administrative mechanism to promote research collaborations; (4) eligibility requirements; (5) review considerations and criteria; (6) preparing an administrative supplement request; (7) post-award requirements; (8) terms of award, (9) administrative and national policy requirements, (10) reporting, (11) application deadline; (12) electronic submission, (13) mailing address for paper submission; and (14) contact information for inquiries.
Background
The DCB supports research that enhances our understanding of the basic mechanisms underlying the onset and progression of cancers. DCB supports and funds grants in basic cancer cell biology, tumor biology and metastasis, cancer immunology and hematology, cancer etiology (including chemical & physical carcinogenesis, and viral carcinogenesis), mechanisms underlying DNA and chromosome aberrations, and structural biology and technology development. Many of the most novel and exciting advances in cancer research derive from the integration of findings from previously disparate fields of research. For such advances to be made, it is necessary for researchers with varying interests (possibly in differing fields) to initiate collaborative research interactions. Through the DCB-APRC Program, NCI can provide administrative supplements to DCB grantees for such interactions.
Examples:
- Collaborations that allow the participants to move into new and important areas of cancer research;
- Collaborations that include expertise from other fields, and thereby have the potential to expand the pool of talented scientists working in cancer research areas; and
- Collaborations that bring a novel approach to an important area of cancer research.
Full Document: HTML / DOC (download Open Office to view document) / PDF (download Adobe Reader to view PDF)